Last update : 05/05/2021 | Version : 1 | ID : 73679
General | |
Identification | |
Detailed name | Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2 |
Sign or acronym | NICORISCOVID |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | APHP200663 |
General Aspects | |
Medical area |
Infectious diseases |
Study in connection with Covid-19 |
Yes |
Health determinants |
Lifestyle and behavior |
Keywords | tobacco nicotine Covid |
Scientific investigator(s) (Contact) | |
Name of the director | KARMOCHKINE |
Surname | Marina |
Address | Service ImmunoInfectieux<br>Hôtel Dieu<br>Place du Parvis Notre Dame<br>75004 Paris |
Phone | 142348469 |
marina.karmochkine@aphp.fr | |
Unit | no |
Organization | AP-HP |
Collaborations | |
Participation in projects, networks and consortia |
No |
Funding | |
Details | no funding |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | AP-HP |
Organisation status |
Public |
Presence of scientific or steering committees |
Yes |
Labelling and database evaluation | Paris Descartes CRU/CIC |
Additional contact | |
yannick.vacher@aphp.fr | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Case control study |
Database recruitment is carried out by an intermediary |
A population file |
Database recruitment is is made on the basis of: |
Another treatment or procedure |
Database recruitment is carried out as part of an interventional study |
Yes |
Details |
Performed at individual level |
Additional information regarding sample selection. |
Healthcare professionals having attended the Hôtel Dieu Covid screening centre in March-April 2020, tested by nasal SARS CoV2 PCR
CASES: PCR+ CONTROLS: PCR- |
Database objective | |
Main objective | Measure the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2 |
Inclusion criteria |
Care personnel having attended the Hôtel-Dieu Hospital Covid screening centre for symptoms compatible with SARS-CoV2 infection,
-Aged over 18 years, With an email address, -Able to express non-objection (=questionnaire feedback |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
Population covered |
General population |
Pathology | |
Gender |
Male Woman |
Geography area |
Regional |
French regions covered by the database |
Île-de-France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2020 |
Date of last collection (YYYY or MM/YYYY) | 2020 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 1000 |
Data | |
Database activity |
Current data collection |
Type of data collected |
Declarative data |
Declarative data (detail) |
Internet self-questionnaire |
Details of collected declarative data | questionnaire consommation tabac et substituts nicotiniques au moment de la réalisation de la PCR SARS-Cov2 |
Presence of a biobank |
No |
Health parameters studied |
Others |
Other (detail) | tobacco use and nicotine replacements |
Procedures | |
Data collection method | Lime Survey anonymous questionnaire |
Participant monitoring |
No |
Followed pathology | |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05